Everything below concerns peptide bond. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-01-09. Where a claim depends on a specific study, the study is described rather than over-claimed.
The parent whey proteins include beta-lactoglobulin, alpha-lactalbumin, serum albumin, immunoglobulins, and glycomacropeptide, depending on the whey source. Hydrolysis does not remove these sequences; it fragments them into peptides of varying length. The peptide distribution depends on the enzyme specificity, reaction time, temperature, pH, and enzyme-to-substrate ratio. Because the mixture is heterogeneous, a single molecular weight cannot describe the product. Instead, laboratories report a distribution, often spanning from a few hundred to several thousand daltons.
Whey protein hydrolysate appears in foods and supplements where rapid digestion, low viscosity, or reduced intact-protein content is desired. It is distinct from whey protein isolate and concentrate, which contain largely intact proteins, though hydrolysates can be made from either. In infant formula, extensively hydrolyzed whey is used in some specialty products, while partially hydrolyzed forms appear in other formulations. Human health effects depend on the specific peptide mixture and are not uniform across all hydrolysates.
Whey protein hydrolysate is a dairy ingredient produced when whey proteins are treated with proteolytic enzymes or, less commonly, acid or heat under controlled conditions. The treatment cleaves peptide bonds and yields shorter peptide chains than those found in intact whey protein. The starting material is usually sweet whey or acid whey from cheese manufacture, concentrated by membrane filtration before hydrolysis. The resulting ingredient retains many amino acids from the original protein but differs in molecular size, solubility, and taste profile.
Whey protein hydrolysate is a dairy ingredient made by treating whey protein with proteases that cleave peptide bonds. The starting material is typically whey protein concentrate or isolate, which contains beta-lactoglobulin, alpha-lactalbumin, and smaller amounts of bovine serum albumin and immunoglobulins. Hydrolysis shortens protein chains into peptides and free amino acids, changing solubility, viscosity, and flavor compared with intact whey protein. The extent of cleavage is commonly described by degree of hydrolysis, a percentage of broken peptide bonds relative to total bonds.
Enzyme choice influences the peptide size distribution and the resulting functional properties. Some proteases cut at specific amino acid residues, while others act more broadly, so two hydrolysates with the same degree of hydrolysis can differ in peptide sequences. Short peptides are generally more water-soluble and less likely to form gels under heat, although bitterness can increase when hydrophobic residues become exposed. The relationship between peptide length, taste, and bioactivity is an active area of study, and not all proposed effects are established in human trials.
Composition tables often report protein content on a dry basis, ash, moisture, fat, and lactose. Because hydrolysis adds water to peptide bonds, the total mass yield can appear slightly higher than the original protein if residual salts and water are counted. Some products are further processed by ultrafiltration, spray drying, or decolorization, which alters mineral content and flavor. Product labels may distinguish partially hydrolyzed from extensively hydrolyzed whey, but these terms are not always defined by a single numerical threshold across regions.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | Whey hydrolysate; hydrolyzed whey protein | Abbreviations such as WPH appear in ingredient lists |
| Appearance | Off-white to light cream powder | Color can vary with starting whey and drying method |
| Solubility class | Highly soluble in water | Short peptides often dissolve more readily than intact whey protein |
| Typical storage temperature | 15–25 °C | Cool, dry conditions limit moisture uptake and browning reactions |
| Typical analytical method | Size-exclusion chromatography | Used to estimate molecular weight distribution of peptides |
Whey protein hydrolysate powders are hygroscopic and can absorb moisture from air. Moisture uptake may lead to caking, reduced flowability, and gradual peptide degradation. Manufacturers typically specify cool, dry storage and sealed packaging to limit these changes. Water activity, rather than water content alone, is often monitored because it better predicts microbial and chemical stability. High temperatures can accelerate Maillard reactions between peptides and residual sugars, altering color and flavor. Exact shelf lives depend on formulation, packaging, and initial moisture, so they are usually determined by product-specific stability testing.
Analytical testing for whey protein hydrolysate focuses on peptide size distribution, degree of hydrolysis, protein content, moisture, ash, and microbiological quality. Size-exclusion chromatography and mass spectrometry can characterize peptide profiles, while Kjeldahl or combustion methods estimate total nitrogen and protein. Amino acid analysis quantifies free and total amino acids. Because peptide mixtures are complex, no single method captures every property, and results can vary between laboratories. Standardized methods and reference materials help improve comparability, but full sequence-level characterization remains uncommon in routine quality control.
Regulatory treatment of whey protein hydrolysate depends on the country and intended use. In many jurisdictions it is regulated as a food ingredient or food for special dietary use, not as a drug. Labeling rules govern allergen statements, protein content claims, and ingredient names. Some markets have specific rules for infant formula ingredients, where hydrolysates may be used for particular dietary purposes. Regulations generally focus on safety, truthful labeling, and manufacturing standards rather than on therapeutic effects. Scientific questions about specific peptide activities remain an active area of research rather than a settled regulatory category.
Production typically begins with pasteurization and concentration of whey. A protease is added under controlled temperature and pH, and the reaction is stopped by heat or pH change when the target extent of cleavage is reached. Ultrafiltration or diafiltration may remove enzymes, salts, and small molecules. The liquid is then spray dried into a powder. Process parameters shape bitterness, solubility, and peptide size. Established control points include enzyme type, reaction time, and inactivation conditions. How these variables interact across large-scale batches remains an area of active process development.
Hydrolysates usually contain 70% to 90% protein on a dry basis, with variable ash, fat, and carbohydrate. Solubility in water is generally high over a broad pH range, though bitter notes can appear from exposed hydrophobic peptides. The powder tends to absorb moisture and may brown during prolonged warm storage. Applications span sports nutrition, clinical nutrition, infant formulas, and flavor systems. Regulatory status and labeling rules differ by country. A key open question is whether a given peptide profile reliably predicts functional or sensory behavior across different food matrices.
Whey protein hydrolysate is a dairy ingredient produced by treating whey protein concentrate or isolate with proteolytic enzymes, acids, or heat under controlled conditions. The process cleaves peptide bonds and reduces average peptide size compared with intact whey proteins. Products are often described by degree of hydrolysis, which estimates the percentage of peptide bonds broken. Hydrolysates occupy a distinct category from concentrates and isolates because their peptide profile, solubility, and taste differ, even when the parent protein source is similar. Commercial production typically begins with pasteurized whey, followed by filtration, enzymatic treatment, inactivation, and drying.
Enzyme choice, pH, temperature, time, and substrate concentration influence the resulting peptide distribution. Endopeptidases cut internal peptide bonds, while exopeptidases remove terminal amino acids and can reduce bitterness. Manufacturers may combine enzymes or use membrane filtration to select peptide size ranges. A higher degree of hydrolysis generally means more small peptides and free amino acids, but it does not by itself define biological activity or nutritional quality. Batch-to-batch variation arises from raw whey composition, enzyme specificity, and processing parameters, so specification ranges are common in commercial supply.
Dried hydrolysate powders are usually off-white to pale yellow and are marketed as free-flowing powders or liquid concentrates. They are used in foods, beverages, and specialized nutrition products where rapid dispersion or reduced allergenicity is desired, although residual allergenic epitopes can remain depending on hydrolysis extent. The term hydrolysate does not imply a single molecular weight cutoff or a guaranteed clinical effect. Labels may state degree of hydrolysis, protein content, or peptide length profile, but analytical definitions vary across suppliers and jurisdictions.
=== 1970s === Following Giant-Size X-Men, the X-Men comic was revived with issue #94 (August 1975), drawn by Cockrum and written by Chris Claremont. Wolverine is initially overshadowed by the other characters, although he creates tension in the team as he is attracted to Cyclops' girlfriend, Jean Grey. As the series progressed, Claremont considered dropping Wolverine from the comic; Cockrum's successor, artist John Byrne, championed the character, later explaining that as a Canadian himself he did not want to see the only Canadian character dropped. Byrne modeled his rendition of Wolverine on actor Paul D'Amato, who played Dr. Hook in the sports film Slap Shot (1977). Cockrum introduced another costume for Wolverine in the final issue of his run, but it was dropped at the start of Byrne's run because he found it difficult to draw. Wolverine was first drawn without his mask in X-Men #98 (April 1976); his distinctive hairstyle became one of his trademarks. The same issue also established that Wolverine's claws are an integrated part of his anatomy. X-Men #100 introduces the "fastball special", a combat maneuver in which the super-strong Colossus throws Wolverine at a distance as if he were a projectile weapon; this tactic recurs in many future battles. Stories of the late 1970s establish Wolverine's murky past and unstable nature, which he battles to keep in check. Wolverine's name was revealed as "Logan" in X-Men #103 (February 1977); Claremont drew inspiration from Canada's Mount Logan, liking "the idea [of] the tallest mountain being the name of the shortest character".
In most organisms non-coding genes (ncRNA) are transcribed as precursors that undergo further processing. In the case of ribosomal RNAs (rRNA), they are often transcribed as a pre-rRNA that contains one or more rRNAs. The pre-rRNA is cleaved and modified (2′-O-methylation and pseudouridine formation) at specific sites by approximately 150 different small nucleolus-restricted RNA species, called snoRNAs. SnoRNAs associate with proteins, forming snoRNPs. While snoRNA part basepair with the target RNA and thus position the modification at a precise site, the protein part performs the catalytical reaction. In eukaryotes, in particular a snoRNP called RNase, MRP cleaves the 45S pre-rRNA into the 28S, 5.8S, and 18S rRNAs. The rRNA and RNA processing factors form large aggregates called the nucleolus. In the case of transfer RNA (tRNA), for example, the 5′ sequence is removed by RNase P, whereas the 3′ end is removed by the tRNase Z enzyme and the non-templated 3′ CCA tail is added by a nucleotidyl transferase. In the case of micro RNA (miRNA), miRNAs are first transcribed as primary transcripts or pri-miRNA with a cap and poly-A tail and processed to short, 70-nucleotide stem-loop structures known as pre-miRNA in the cell nucleus by the enzymes Drosha and Pasha. After being exported, it is then processed to mature miRNAs in the cytoplasm by interaction with the endonuclease Dicer, which also initiates the formation of the RNA-induced silencing complex (RISC), composed of the Argonaute protein.
After Banting's death, Best "claimed that the crucial innovation of using alcohol to remove toxic impurities had largely been his own", even though this had actually been Collip's key contribution. In 1972, an official history of the Nobel Committee declared that omitting Best might have been a mistake. In fact, Best was not considered because he was never nominated. Nomination for a Nobel Prize can only be made by certain individuals, including former recipients of the Prize, and his central role along with Banting was not known to those who had the ability to make nominations. Best was subsequently nominated for the 1950 Nobel Prize in physiology based on his work on choline and heparin. At the Centenary Celebration of the Nobel Prize for the Discovery of Insulin held by the Toronto Medical Society on November 27, 2023, Professor Erling Norrby, former chair of the Nobel Assembly at the Karolinska Institute, made a presentation - The Optimal Nobel Prize for Physiology or Medicine and presented the following information from the Nobel archives: “Best was nominated 14 times 1950-1954. The main nominator was Henry Dale who had been supervisor for Best’s Ph.D. work. The discovery proposed to be awarded was Best’s work on the lipotropic effect of choline, but Dale argued that separately that Best should have shared the 1923 prize to Banting. Best was subject to four evaluations by Ulf von Euler who gave support to Dale’s nomination. Although Best was declared worthy of a prize (1951, 1952, 1954) he never received it.”
Sources: en.wikipedia.org
PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitor anticancer drugs that block the activity of PD-1 and PD-L1 immune checkpoint proteins present on the surface of cells. Immune checkpoint inhibitors are emerging as a front-line treatment for several types of cancer. PD-1 and PD-L1 inhibitors act to inhibit the association of the programmed death-ligand 1 (PD-L1) with its receptor, programmed cell death protein 1 (PD-1). The interaction of these cell surface proteins is involved in the suppression of the immune system and occurs following infection to limit the killing of bystander host cells and prevent autoimmune disease. This immune checkpoint is also active in pregnancy, following tissue allografts, and in different types of cancer.
The thyroid gland also produces the hormone calcitonin, which helps regulate blood calcium levels. Parafollicular cells produce calcitonin in response to high blood calcium. Calcitonin decreases the release of calcium from bone, by decreasing the activity of osteoclasts, cells which break down bone. Bone is constantly reabsorbed by osteoclasts and created by osteoblasts, so calcitonin effectively stimulates movement of calcium into bone. The effects of calcitonin are opposite those of the parathyroid hormone (PTH) produced in the parathyroid glands. However, calcitonin seems far less essential than PTH, since calcium metabolism remains clinically normal after removal of the thyroid (thyroidectomy), but not the parathyroid glands.
In both cases, Oedipus can therefore be recognized as a "liminal" or threshold figure, helping effect the transition between the old religious practices, represented by the death of the Sphinx, and the rise of the new, Olympian gods.
Sources: en.wikipedia.org
Marlowe (1988), creator of Castle; writer of Air Force One, End of Days, and Hollow Man Lawrence Trilling (1988), showrunner of Parenthood and Goliath Maiken Baird (1989), documentary film producer, Client 9: The Rise and Fall of Eliot Spitzer Sam Bisbee (1990), Emmy Award-winning producer and composer Gina Fattore (1990), producer and writer of Dawson's Creek, Gilmore Girls, Parenthood, creator of Dare Me Jeff Rake (1990), television producer, writer of Boston Legal and creator of Manifest and The Mysteries of Laura Dede Gardner (1990), Academy Award-winning producer of 12 Years a Slave; president of Plan B Entertainment Jenji Kohan (1991), television writer, producer, creator of Orange Is the New Black and Weeds Ari Gold (1992), filmmaker, director of Adventures of Power Elizabeth Craft (1993), producer, screenwriter, Fantasy Island, The 100, Lie to Me Ethan McSweeny (1993), former artistic director of the American Shakespeare Center, recipient of a 2018 Helen Hayes Award Brian Yorkey (1993), playwright, co-winner of the 2010 Pulitzer Prize for Drama for writing the musical Next to Normal Anna Winger (1993), screenwriter, creator of miniseries Deutschland 83, Deutschland 86, and Unorthodox Imara Jones (1994), political journalist and director Nicole Kassell (1994), director and producer of Watchmen, winner of the 2020 Directors Guild of America Award for Outstanding Directing – Drama Series Tim Carvell (1995), head writer of The Daily Show and executive producer of Last Week Tonight with John Oliver Josh Fox (1995), Academy Award-nominated documentary director, Gasland Adam Egypt Mortimer (1995), director of Daniel Isn't Real, Archenemy Henry Alex Rubin (1995), Academy Award-nominated director, Murderball Julius Sharpe (1995), television writer and showrunner of Making History and United We Fall Ramin Bahrani (1996), writer-director of Man Push Cart, Chop Shop and Fahrenheit 451, 2021 Academy Award for Best Adapted Screenplay nominee Moira Demos (1996), filmmaker who produced Netflix documentary Making a Murderer Yana Gorskaya (1996), Academy Award-nominated film editor, Spellbound Cetywa Powell (1996), director and fine art photographer Courtney Lilly (1997), television producer, showrunner of Black-ish, Grown-ish, Mixed-ish Nancy Schwartzman (1997), director, Roll Red Roll Beau Willimon (1999), creator and producer of House of Cards; writer of the play Farragut North Vikram Gandhi (2000), director, Kumaré, Barry, reporter for Vice Andrew Goldberg (2000), creator of Netflix series Big Mouth Ned Benson (2001), director, The Disappearance of Eleanor Rigby Dan Harris (2001), Saturn Award-winning screenwriter, X2, Superman Returns; director, Imaginary Heroes Andrew Neel (2001), filmmaker, director of King Kelly, Goat Anna Boden (2002), co-writer of Half Nelson and director of Sugar, Captain Marvel Tze Chun (2002), award-winning director, Children of Invention Lang Fisher (2002), co-creator of Never Have I Ever, writer of 30 Rock and Brooklyn Nine-Nine, Peabody Award winner in 2008 Susanna Fogel (2002), Emmy Award and BAFTA Award-nominated director Will Graham (2002), creator of the Onion News Network, showrunner of Mozart in the Jungle, Peabody Award winner in 2008 Ashley Lyle (2002), screenwriter, showrunner of Yellowjackets Justin Marks (2002), screenwriter, The Jungle Book, Counterpart Katori Hall (2003), playwright, The Mountaintop, winner of the 2021 Pulitzer Prize for Drama Raamla Mohamed (2003), Emmy Award-nominated screenwriter, Little Fires Everywhere Graham Moore (2003), winner of the 2015 Academy Award for Best Adapted Screenplay for his screenplay of The Imitation Game Lucia Aniello (2004), director of Rough Night and Time Traveling Bong Gabe Liedman (2004), creator of Q-Force, writer of Brooklyn Nine-Nine, PEN15, Inside Amy Schumer and Kroll Show Zhang Mo (2005), Chinese director, daughter of Zhang Yimou Laura Goode (2006), author, columnist, and producer of Farah Goes Bang Matt Kaplan (2006), producer of young adult films, To All the Boys franchise Meera Menon (2006), Indian-American director, Equity Lilly Burns (2009), television producer, co-founder of Jax Media and president of Imagine Entertainment Eli Bush (2009), film and theatre producer and winner of the Golden Globe Award in 2018 for Lady Bird Jason Fuchs (2009), actor and screenwriter, Pan, Ice Age: Continental Drift Jessica Kingdon (2009), Academy Award-nominated Chinese-American documentary director Nuotama Bodomo (2010), Ghanaian filmmaker and co-writer of sketch comedy Random Acts of Flyness on HBO Sabaah Folayan (2013), director of documentary Whose Streets?
=== Incubator Lab Facility Investment === When SHIELD Illinois consolidated its labs into two University-owned and operated facilities to optimize logistics during the 2021-2022 school year. The Incubator Lab Facility on the University of Illinois Chicago (UIC) campus, the building where SHIELD Illinois's NextGen sequencing and innovation lab was located, was not originally built to meet the criteria of a CLIA-certified clinical diagnostics lab. So, the program decided to invest in upgrading the facility to bring it up to modern standards. According to Len Musielak, SHIELD Illinois Senior Director of Operations, SHIELD wanted to not only upgrade the building for its purposes but also add in ways that would provide a benefit to other tenants now and far into the future. The project included $2.2 million in upgrades and had a six-week deadline to complete the most difficult tasks and make the lab operational. Facility upgrades included:
== Pharmacology == In 2011, the Bohn lab noted antinociception against both chemically induced and inflammation-derived pain, and experiments indicated lack of opioid receptor modulation, but were unable to define a particular target. A 2019 study by a cross-site Australian and U.S. group discovered through cultured neuronal networks that conolidine may inhibit the Ca v2.2 channel, a mechanism seen in molecules like conotoxin. The group was unable to rule out partial polypharmacology against other targets.
RO5263397, or RO-5263397, is a trace amine-associated receptor 1 (TAAR1) partial or full agonist which is used in scientific research. It is the most well-studied of all of the synthetic TAAR1 ligands. In addition to its use in research, RO5263397 is or was under development for potential clinical use as a medication.
Sources: en.wikipedia.org
It is made from whey, a byproduct of cheese or casein production, or from whey protein concentrate or isolate. Enzymes break the intact whey proteins into shorter peptides. The final composition depends on the starting whey and the hydrolysis conditions.
No. Whey protein isolate is a purified intact protein, while hydrolysate has been enzymatically cleaved into smaller peptides, and hydrolysate can be produced from isolate or concentrate. The two ingredients differ in molecular size, taste, and functional behavior.
Hydrolysis cleaves proteins but does not necessarily remove lactose, which is a sugar. It can reduce the size of allergenic proteins, yet residual peptides may still trigger reactions in sensitive individuals. Allergen status depends on the extent of hydrolysis and must be assessed for each product.
Hydrolysate has undergone enzymatic cleavage of peptide bonds, while isolate is largely intact protein. Both can originate from the same whey stream, but hydrolysis changes peptide size, solubility, taste, and allergenicity testing outcomes. The two ingredients are not interchangeable in every formulation.